Benefits
Capillary Fragility / Bleeding Gum Support
Historical use for capillary fragility, easy bruising, bleeding gums (often combined with vitamin C). Reduces capillary permeability — same mechanism as hesperidin. Long-established clinical positioning.
Venous Insufficiency Adjunct
Rutin (especially as O-(beta-hydroxyethyl)-rutoside / oxerutins / Venoruton®) used for chronic venous insufficiency in Europe. Comparable evidence to hesperidin/diosmin for some indications.
Antioxidant Activity
Direct free radical scavenging plus quercetin-like effects after gut hydrolysis to active aglycone. Broad antioxidant profile contributing to cardiovascular and longevity applications.
Anti-Inflammatory Effects
Inhibits inflammatory cytokine production, reduces NF-κB activation. Modest anti-inflammatory profile.
Mast Cell Protocol Component
Often combined with luteolin and quercetin in MCAS (mast cell activation syndrome) protocols (e.g., NeuroProtek® combinations). Adjunctive to primary mast cell stabilizers.
Mechanism of action
Quercetin Prodrug
Rutin is a glycoside that gets hydrolyzed by gut microbiome to release quercetin (the active aglycone) plus rutinose. Functionally a delayed-release/colon-targeted quercetin source. Bioavailability and tissue distribution differ from free quercetin.
Capillary Permeability Reduction
Decreases capillary leakage — improves capillary integrity. Foundational mechanism for 'bioflavonoid' applications in capillary fragility.
Antioxidant via Free Radical Scavenging
Direct antioxidant activity plus iron-chelating activity. Inhibits lipid peroxidation.
Synergy with Vitamin C
Vitamin C and rutin (and other bioflavonoids) work synergistically — flavonoids stabilize vitamin C by reducing oxidation. Basis for traditional 'vitamin C with bioflavonoids' formulations.
Clinical trials
Multiple RCTs of hydroxyethylrutosides / oxerutins (Venoruton®) for chronic venous insufficiency.
CVI patients across multiple trials.
Oxerutins significantly improve CVI symptoms (edema, pain, leg heaviness). Evidence comparable to MPFF (diosmin/hesperidin). Established treatment in Europe.
Trials of rutin or rutin-containing products for hemorrhoid management.
Hemorrhoid patients.
Modest improvements in bleeding, pain, swelling. Less robust evidence than MPFF (diosmin/hesperidin) but supportive. Reasonable adjunct.
About this ingredient
Rutin (quercetin-3-O-rutinoside) is a FLAVONOID GLYCOSIDE — quercetin attached to rutinose disaccharide. Found primarily in BUCKWHEAT (highest source ~10 mg/g), citrus fruit pith, apples, asparagus, onions, capers, elderberries, sophora japonica buds. Functionally a 'delayed-release quercetin' — gut microbiome hydrolyzes rutin to release active quercetin aglycone in colon.
KEY PRODUCT VARIATIONS: (1) RUTIN — basic glycoside; modest bioavailability; (2) HYDROXYETHYLRUTOSIDES / OXERUTINS (VENORUTON®) — modified rutin with improved bioavailability; established European venous insufficiency drug; (3) TROXERUTIN — single component of oxerutins; sometimes used alone; (4) BIOFLAVONOID COMPLEX — rutin + hesperidin + other citrus flavonoids; traditional with vitamin C.
EVIDENCE-BASED USES: (1) CHRONIC VENOUS INSUFFICIENCY (especially as oxerutins/Venoruton®); (2) Capillary fragility, easy bruising, bleeding gums (historical and current); (3) Hemorrhoid adjunct; (4) Diabetic retinopathy adjunct (microvascular protection); (5) Antioxidant; (6) MCAS adjunct (with luteolin/quercetin).
CRITICAL CAUTIONS: (1) BIOAVAILABILITY — basic rutin oral bioavailability low; oxerutins have improved profile; choose product based on indication; (2) PREGNANCY/LACTATION — supplemental safety data limited; AVOID supplementation; dietary rutin safe; (3) IRON SUPPLEMENTATION — rutin chelates iron; separate by 1-2 hours from iron supplements; relevant for iron-deficient patients; (4) ANTICOAGULANTS — theoretical bleeding risk at very high doses; minor; (5) DOSE — 250-500 mg/day general; up to 1,000 mg/day for therapeutic indications; oxerutins typically 1,000-2,000 mg/day; (6) FOR VENOUS INSUFFICIENCY, oxerutins/Venoruton® has stronger direct evidence than basic rutin; for general bioflavonoid/antioxidant support, basic rutin (often combined with vitamin C) is foundational; (7) MAST CELL PROTOCOLS — rutin is component of NeuroProtek® and similar combinations with luteolin and quercetin; used in MCAS context; (8) BUCKWHEAT — natural dietary source; buckwheat consumption (whole grain or sprouted) provides rutin plus other beneficial compounds; (9) HISTORICAL POSITIONING — rutin was foundational 'vitamin P' (now obsolete term) along with hesperidin and other bioflavonoids — established traditional supplement category; (10) URINE COLOR — yellow-green urine discoloration with rutin is harmless and reflects flavonoid metabolites; not concerning.